| Citation: |
LIU Xue, HUANG Yue, TAN Chunyan, REN Qinglan. Prophylactic Radiotherapy for Procedure Tract Metastases in Malignant Pleural Mesothelioma: A Meta-analysis[J]. Cancer Research on Prevention and Treatment, 2018, 45(5): 289-294. DOI: 10.3971/j.issn.1000-8578.2018.17.1267
|
To systematically evaluate if prophylactic radiotherapy could reduce the incidence of procedure tract metastases(PTMs) in patients with malignant pleural mesothelioma(MPM).
Databases including PubMed, Cochrane Library, Web of Science, Embase were searched to collect studies about prophylactic radiotherapy for procedure tracts in MPM. Two reviewers independently screened literature, extracted data, and evaluated the methodological quality of included studies. Then, meta-analysis was performed using RevMan 5.3 software.
A total of seven studies involving 698 patients were included. Meta-analysis results showed that prophylactic radiotherapy could not reduce the incidence of PTMs in all MPM patients(OR=0.48, 95%CI: 0.22-1.07, P=0.07), but prophylactic radiotherapy could prevent PTMs in the subgroups of large bore procedures(OR=0.39, 95%CI: 0.18-0.84, P=0.02) and histologic type of epithelial MPM(OR=0.21, 95%CI: 0.11-0.69, P=0.006).
The current evidence shows that prophylactic radiotherapy could prevent PTMs in MPM patients undergone large bore procedures(like thoracotomy, thoracoscopy, indwelling pleural catheter insertion) and patients with histologic type of epithelial MPM.
| [1] |
Bibby AC, Tsim S, Kanellakis N, et al. Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment[J]. Eur Respir Rev, 2016, 25(142): 472-86. doi: 10.1183/16000617.0063-2016
|
| [2] |
Boutin C, Rey F, Viallat JR. Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy[J]. Chest, 1995, 108(3): 754-8. doi: 10.1378/chest.108.3.754
|
| [3] |
Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5. 1. 0[EB/OL]. http://handbook.cochrane.org.
|
| [4] |
GA Wells, B Shea, D O'Connell, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses[EB/OL]. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
|
| [5] |
Cellerin L, Garry P, Mahe MA, et al. Malignant pleural mesothelioma: radiotherapy for the prevention of seeding nodules[J]. Rev Mal Respir, 2004, 21(1): 53-8. doi: 10.1016/S0761-8425(04)71235-8
|
| [6] |
Bydder S, Phillips M, Joseph DJ, et al. A randomised trial of single-dose radiotherapy to prevent procedure tract metastasis by malignant mesothelioma[J]. Br J Cancer, 2004, 91(1): 9-10. doi: 10.1038/sj.bjc.6601957
|
| [7] |
O'Rourke N, Garcia JC, Paul J, et al. A randomised controlled trial of intervention site radiotherapy in malignant pleural mesothelioma[J]. Radiother Oncol, 2007, 84(1): 18-22. doi: 10.1016/j.radonc.2007.05.022
|
| [8] |
Clive AO, Taylor H, Dobson L, et al. Prophylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (SMART): a multicentre, open-label, phase 3, randomised controlled trial[J]. Lancet Oncol, 2016, 17(8): 1094-104. doi: 10.1016/S1470-2045(16)30095-X
|
| [9] |
Chapman A, Mulrennan S, Ladd B, et al. Population based epidemiology and prognosis of mesothelioma in Leeds, UK[J]. Thorax, 2008, 63(5): 435-9. doi: 10.1136/thx.2007.081430
|
| [10] |
Froment MA, Fréchette E, Dagnault A. Prophylactic irradiation of intervention sites in malignant pleural mesothelioma[J]. Radiother Oncol, 2011, 101(2): 307-10. doi: 10.1016/j.radonc.2011.08.038
|
| [11] |
Sun Y, Yu H, Ma J, et al. The Role of 18F-FDG PET/CT Integrated Imaging in Distinguishing Malignant from Benign Pleural Effusion[J]. PLoS One, 2016, 11(8): e161764. http://www.ncbi.nlm.nih.gov/pubmed/27560933
|
| [12] |
Husain AN, Colby TV, Ordóñez NG, et al. Guidelines for Pathologic Diagnosis of Malignant Mesothelioma: 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group[J]. Arch Pathol Lab Med, 2018, 142(1): 89-108. doi: 10.5858/arpa.2017-0124-RA
|
| [13] |
Davies HE, Musk AW, Lee YC. Prophylactic radiotherapy for pleural puncture sites in mesothelioma: the controversy continues[J]. Curr Opin Pulm Med, 2008, 14(4): 326-30. doi: 10.1097/MCP.0b013e3282fcea50
|
| [14] |
Agarwal PP, Seely JM, Matzinger FR, et al. Pleural mesothelioma: sensitivity and incidence of needle track seeding after image-guided biopsy versus surgical biopsy[J]. Radiology, 2006, 241(2): 589-94. doi: 10.1148/radiol.2412051020
|
| [15] |
Metintas M, Ak G, Parspour S, et al. Local recurrence of tumor at sites of intervention in malignant pleural mesothelioma[J]. Lung Cancer, 2008, 61(2): 255-61. doi: 10.1016/j.lungcan.2007.12.022
|
| [16] |
Thomas R, Budgeon CA, Kuok YJ, et al. Catheter tract metastasis associated with indwelling pleural catheters[J]. Chest, 2014, 146(3): 557-62. doi: 10.1378/chest.13-3057
|
| [17] |
Matsuo Y, Shibuya K, Okubo K, et al. Long-term outcomes of intensity-modulated radiotherapy following extra-pleural pneumonectomy for malignant pleural mesothelioma[J]. Acta Oncol, 2017, 56(7): 957-62. doi: 10.1080/0284186X.2017.1279749
|
| [18] |
Perrot M, Wu L, Wu M, et al. Radiotherapy for the treatment of malignant pleural mesothelioma[J]. Lancet Oncol, 2017, 18(9): e532-42. doi: 10.1016/S1470-2045(17)30459-X
|
| [19] |
Boonstra AM, Schiphorst Preuper HR, Balk GA, et al. Cut-off points for mild, moderate, and severe pain on the visual analogue scale for pain in patients with chronic musculoskeletal pain[J]. Pain, 2014, 155(12): 2545-50. doi: 10.1016/j.pain.2014.09.014
|
| [20] |
Vogelzang NJ, Rusthoven JJ, Symanowski J, et al. Phase Ⅲ study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma[J]. J Clin Oncol, 2003, 21(14): 2636-44. doi: 10.1200/JCO.2003.11.136
|
| [21] |
Bibby AC, Maskell NA. Pleural biopsies in undiagnosed pleural effusions; Abrams vs image-guided vs thoracoscopic biopsies[J]. Curr Opin Pulm Med, 2016, 22(4): 392-8. doi: 10.1097/MCP.0000000000000258
|
| [1] | LIANG Tong, LIU Huajie, DA Mingxu. Metabolic Syndrome and Risk of Gastric Cancer: A Meta-analysis[J]. Cancer Research on Prevention and Treatment, 2021, 48(3): 268-273. DOI: 10.3971/j.issn.1000-8578.2021.20.0957 |
| [2] | SHAO Lihua, ZHANG Qiuning, LUO Hongtao, YANG Zhen, LIU Ruifeng, TIAN Jinhui, LI Zheng, WANG Xiaohu, YANG Kehu. Carbonions and Proton Therapy for Hepatocellular Carcinoma: A Meta-analysis[J]. Cancer Research on Prevention and Treatment, 2020, 47(5): 358-366. DOI: 10.3971/j.issn.1000-8578.2020.19.1158 |
| [3] | KUANG Yuhui, CHEN Xinju, XU Fangbiao. Meta-analysis of Efficacy and Safety of Jinlong Capsule Combined with Chemoradiotherapy on Liver Metastases[J]. Cancer Research on Prevention and Treatment, 2020, 47(1): 63-69. DOI: 10.3971/j.issn.1000-8578.2020.19.0619 |
| [4] | RAO Xionghui, LUO Hongliang, HUANG Jun, ZHU Zhengming. Prognostic and Clinicopathological Significance of PD-L1 Expression for Colorectal Cancer: A Meta-analysis[J]. Cancer Research on Prevention and Treatment, 2019, 46(11): 1013-1021. DOI: 10.3971/j.issn.1000-8578.2019.19.0363 |
| [5] | JIAN Yaowen, XIONG Wenjing, LIU Ye, LIU Yang, YANG Huixian, RANG Weiqing. A Meta-analysis on Relationship of Dietary Factors with Liver Cancer in Chinese Population[J]. Cancer Research on Prevention and Treatment, 2017, 44(7): 493-500. DOI: 10.3971/j.issn.1000-8578.2017.16.1465 |
| [6] | TAN Yi, LIU Yan, SONG Yuwei, CHEN Qiufang, TAN Guoqiang, GUI Xiujuan, LIN Shaoqiang. Prognostic Value of Circulating Tumor Cells for Metastatic Prostate Cancer: A Meta-analysis[J]. Cancer Research on Prevention and Treatment, 2016, 43(9): 783-788. DOI: 10.3971/j.issn.1000-8578.2016.09.011 |
| [7] | Zhang Xueyan, Guo Wenjie, Zhou Yongkang. Meta-analysis on Relationship between runx3 Gene and Hepatocellular Carcinoma[J]. Cancer Research on Prevention and Treatment, 2013, 40(03): 268-272. DOI: 10.3971/j.issn.1000-8578.2013.03.012 |
| [8] | LV Peng, HU Zhi-jian. A Meta Analysis on Relationship between Alcohol Dehydrogenase2 Polymorphisms and Risk of Esophageal Cancer[J]. Cancer Research on Prevention and Treatment, 2011, 38(05): 579-583. DOI: 10.3971/j.issn.1000-8578.2011.05.027 |
| [9] | QIU Yue-feng, CAI Lin. Meta-analysis on Relationship between Body Mass Index and Lung Cancer Risk[J]. Cancer Research on Prevention and Treatment, 2010, 37(02): 218-222. DOI: 10.3971/j.issn.1000-8578.2010.02.025 |
| [10] | ZHONG Qiu-an, QIU Xiao-qiang, JIANG Jun-jun, DENG Ying-ying, YU Hong-ping. Association between Diabetes Mellitus and Hepatocellular Carcinoma: A Meta- analysis of Cohort Study[J]. Cancer Research on Prevention and Treatment, 2010, 37(01): 97-100. DOI: 10.3971/j.issn.1000-8578.2010.01.027 |
This work is licensed under a Creative Commons Attribution 3.0 License.
Copyright © Editorial Department of Cancer Prevention Research 鄂公网安备 42011102005013号 鄂ICP备2022015867号
Supported by: Beijing Renhe Information Technology Co., Ltd. 
DownLoad: